I definitely understand the investor side of the lower than anticipated number, but this was only Q1 and without CA numbers accounted for we have potential to make this up and then some! Much expansion yet to come. Young company learning the hard way at times. To some expense at our investment initially...

Time to buy! Still up approximately 50% ! More growth inevitable with new labs forthcoming!